Oropharyngeal application of colostrum or mother’s own milk in preterm infants: a systematic review and meta-analysis
- 30 January 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 81 (10) , 1254-1266
Abstract
Context: Many preterm neonates often cannot be fed enterally and hence do not receive the benefits of colostrum. Oropharyngeal application of colostrum is a novel way of harnessing the immunological benefits of colostrum. Randomized controlled trials (RCTs) investigating the efficacy of this approach have shown variable results. Objective: The aim of this systematic review was to synthesize available data on the effect of oropharyngeal application of colostrum or mother's own milk (CMOM) in preterm infants. Data Sources: Six electronic databases (MEDLINE, Embase, CINAHL, Scopus, Web of Science, and Cochrane Library) were searched until January 13, 2022. Only RCTs comparing oral application of CMOM with placebo/routine care in preterm infants were eligible. Studies enrolling term neonates or administering enteral feeds were excluded. Data Extraction: Two investigators independently extracted data using a structured proforma. Data Analysis: The Cochrane Risk of Bias 2 tool was used to assess bias. Random-effects meta-analysis was undertaken using RevMan 5.4 software. From 2787 records identified, 17 RCTs enrolling 4106 preterm infants were included. There was no significant difference between groups in incidence of necrotizing enterocolitis (NEC) stage 2 or higher (RR = 0.65; 95%CI, 0.36–1.20; 1089 participants in 12 trials). Application of CMOM significantly reduced the incidence of sepsis (RR = 0.72; 95%CI, 0.56–0.92; 1511 participants in 15 studies) and any stage of NEC (RR = 0.58; 95%CI, 0.37–0.92; 1616 participants in 16 trials). The CMOM group achieved full enteral feeds 1.75 days sooner (95%CI, 0.3–3.2 days; 1580 participants in 14 studies) and had higher weight at discharge (MD = 43.9 g; 95%CI, 3–85 g; 569 participants in 3 studies). There were no statistically significant differences in other outcomes. Conclusions: Evidence with low to very low certainty suggests CMOM has a beneficial effect on NEC (any stage), sepsis, and time to full enteral feeds. Given its low cost and minimal risk of harm, routine CMOM use may be considered in preterm neonates. Prospero Registration Number: CRD42021262763Keywords
This publication has 32 references indexed in Scilit:
- Oropharyngeal Administration of Colostrum Increases Salivary Secretory IgA Levels in Very Low-Birth-Weight InfantsAmerican Journal of Perinatology, 2017
- Oral colostrum priming shortens hospitalization without changing the immunomicrobial milieuJournal of Perinatology, 2016
- Buccal administration of human colostrum: impact on the oral microbiota of premature infantsJournal of Perinatology, 2015
- Oropharyngeal administration of mother’s colostrum, health outcomes of premature infants: study protocol for a randomized controlled trialTrials, 2015
- Oropharyngeal Colostrum Administration in Extremely Premature Infants: An RCTPediatrics, 2015
- Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infantsPediatric Research, 2014
- A Pilot Study to Determine the Safety and Feasibility of Oropharyngeal Administration of Own Mother's Colostrum to Extremely Low-Birth-Weight InfantsAdvances in Neonatal Care, 2010
- Cytokines Associated With Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight InfantsPediatrics, 2009
- Revised Indications for the Treatment of Retinopathy of PrematurityArchives of Ophthalmology (1950), 2003
- Necrotizing Enterocolitis: Treatment Based on Staging CriteriaPediatric Clinics of North America, 1986